These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 457253)

  • 21. [Staphylococcal toxic shock exotoxin (its isolation and characteristics)].
    Akatov AK; Fluer FS; Ratgauz GL; Kushko IV
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Oct; (10):15-20. PubMed ID: 3541462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Isolation and characterization of erythrogenic toxins. VII. Study of the erythrogenic toxin type C produced by Streptococcus pyogenes].
    Ozegowski JH; Knöll H; Gerlach D; Köhler W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):38-50. PubMed ID: 6431714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification and some physicochemical properties of toxic-shock toxin.
    Reiser RF; Robbins RN; Khoe GP; Bergdoll MS
    Biochemistry; 1983 Aug; 22(16):3907-12. PubMed ID: 6615808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A study on the pathogenesis of Streptococcus mitis exotoxin].
    Lu H; Weng X; Yin Y; Chen Y; Jiang X; Wang H; Qian K; Zhu B; Peng B; Gong Z
    Zhonghua Nei Ke Za Zhi; 2001 Jan; 40(1):29-31. PubMed ID: 11798555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HOST-PARASITE RELATIONSHIPS AMONG GROUP A STREPTOCOCCI. 3. DEPRESSION OF RETICULOENDOTHELIAL FUNCTION BY STREPTOCOCCAL PYROGENIC EXOTOXINS.
    HANNA EE; WATSON DW
    J Bacteriol; 1965 Jan; 89(1):154-8. PubMed ID: 14255656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and distribution of a new enterotoxin-related superantigen produced by Staphylococcus aureus.
    Abe J; Ito Y; Onimaru M; Kohsaka T; Takeda T
    Microbiol Immunol; 2000; 44(2):79-88. PubMed ID: 10803494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential role of bacterial superantigens in the pathogenesis of Kawasaki syndrome.
    Leung DY; Meissner C; Fulton D; Schlievert PM
    J Clin Immunol; 1995 Nov; 15(6 Suppl):11S-17S. PubMed ID: 8613483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Isolation and characterization of erythrogenic toxins. VIII. Purification of a biologically active protein of the molecular weight 10,000 (LMP-10k) from filtrates of Streptococcus pyogenes, strain NY-5. Relationship to erythrogenic toxin type A].
    Gerlach D; Ozegowski JH; Knöll H; Köhler W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Feb; 261(1):75-84. PubMed ID: 3518295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A purified group A streptococcal pyrogenic exotoxin. Physiochemical and biological properties including the enhancement of susceptibility to endotoxin lethal shock.
    Kim YB; Watson DW
    J Exp Med; 1970 Mar; 131(3):611-22. PubMed ID: 4905084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Purification and characterization of erythrogenic toxins. I. Investigation of erythrogenic toxin A produced by Streptococcus pyogenes strain NY-5 (author's transl)].
    Gerlach D; Knöll H; Köhler W
    Zentralbl Bakteriol A; 1980; 247(2):177-91. PubMed ID: 6775448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A simple procedure for the purification of staphylococcal alpha-toxin.
    Dalen AB
    Acta Pathol Microbiol Scand B; 1976 Dec; 84B(6):326-32. PubMed ID: 11636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonspecific T-lymphocyte mitogenesis by pyrogenic exotoxins from group A streptococci and Staphylococcus aureus.
    Schlievert PM; Schoettle DJ; Watson DW
    Infect Immun; 1979 Sep; 25(3):1075-7. PubMed ID: 387590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of human interleukin-1 by toxic-shock-syndrome toxin-1.
    Parsonnet J; Hickman RK; Eardley DD; Pier GB
    J Infect Dis; 1985 Mar; 151(3):514-22. PubMed ID: 3871826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of toxic shock syndrome toxin-secreting and exfoliative toxin-secreting Staphylococcus aureus with Kawasaki syndrome complicated by coronary artery disease.
    Leung DY; Sullivan KE; Brown-Whitehorn TF; Fehringer AP; Allen S; Finkel TH; Washington RL; Makida R; Schlievert PM
    Pediatr Res; 1997 Sep; 42(3):268-72. PubMed ID: 9284264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Affinity purification of staphylococcal toxic shock syndrome toxin 1 and its pathologic effects in rabbits.
    Reeves MW; Arko RJ; Chandler FW; Bridges NB
    Infect Immun; 1986 Feb; 51(2):431-9. PubMed ID: 3943896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome.
    Leung DY; Meissner HC; Fulton DR; Murray DL; Kotzin BL; Schlievert PM
    Lancet; 1993 Dec; 342(8884):1385-8. PubMed ID: 7901681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Group A streptococcal phage T12 carries the structural gene for pyrogenic exotoxin type A.
    Johnson LP; Schlievert PM
    Mol Gen Genet; 1984; 194(1-2):52-6. PubMed ID: 6374381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and characterization of erythrogenic toxins. V. Communication: identity of erythrogenic toxin type B and streptococcal proteinase precursor.
    Gerlach D; Knöll H; Köhler W; Ozegowski JH; Hríbalova V
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Sep; 255(2-3):221-33. PubMed ID: 6359775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification and properties of Clostridium botulinum type F toxin.
    Yang KH; Sugiyama H
    Appl Microbiol; 1975 May; 29(5):598-603. PubMed ID: 807160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Qualitative and quantitative methods for detecting staphylococcal epidermolytic toxin.
    Arbuthnott JP; Billcliffe B
    J Med Microbiol; 1976 May; 9(2):191-201. PubMed ID: 819654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.